SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ — Bremen Co., Ltd., a leading Korean pet specialty company, is expanding into Japan with its premium treat, the Bremen Roasted Hwangtae Snack. Created for safe and shared enjoyment by both pets and their owners, the snack will make its official debut on the Japanese crowdfunding platform Makuake on December 10.

The Bremen Roasted Hwangtae Snack is produced under a strict human-grade system, ensuring it meets the same high standards applied to food for people. To guarantee safety for companion animals, the hwangtae undergoes a thorough salt-removal process before being roasted on a 300°C iron plate. This high-heat method eliminates bacteria, including E. coli and coliforms, while enhancing the naturally clean and savory flavor of premium hwangtae.

Highly palatable and light in texture, the snack provides a crispy and enjoyable eating experience, making it ideal for daily consumption. It is versatile enough for dogs, cats, hedgehogs, parrots, and various small animals. Cats, in particular, enjoy the treat when it is softened in warm water, which enhances its aroma and texture.

Hwangtae is considered one of Korea’s most premium dried fish ingredients, containing more than 90% protein. It is produced through a natural freezing-and-thawing method repeated over four months in cold, high-altitude regions where temperatures fall below –10°C. This unique process creates a nutrient-rich ingredient distinct from ordinary dried fish like bugeo, making it suitable for pets of all ages, from young animals to seniors.

With this launch, Bremen aims to promote a culture of shared snacking, strengthening emotional bonds between pets and their owners through healthy and trustworthy treats.

Bremen has continued to expand its global presence with innovative pet food and pet-tech solutions. In 2021, the company achieved 1,543% of its funding goal on Makuake with its pioneering cat-litter product, Bremen Popcorn Tofu, which remains popular in Japan. Bremen plans to further grow its product lineup to support a premium K-PET lifestyle worldwide.

Looking ahead, Bremen will introduce the Bremen Pet Tag, an IoT wearable device that connects with the Petstapic platform, in the first quarter of 2026. The app offers features such as sharing information about abandoned animals, connecting with nearby pet friends, and tracking walks. The Japanese version of the app is now available on both Android and iOS.

• Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential
• Synergistic and complementary to Lee’s Pharm’s existing products pipeline, and
• Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global partnership with UCB

HONG KONG, Dec. 10, 2025 /PRNewswire/ — Nova Pneuma Inc. (“NPI”), the Delaware incorporated and wholly owned subsidiary of Lee’s Pharmaceutical Holdings Limited (0950.HK) (“Lee’s Pharm” or the “Company”), announced today the assets acquisition from Alexza Pharmaceuticals, Inc. (“Alexza”). The transaction grants Lee’s Pharm and NPI, the full ownership of the Staccato® One Breath Technology® (“Staccato® OBT®”) platform and assets in relation to Staccato® OBT®, including intellectual property, know-how, trademarks, product pipeline, equipment, products and access to GMP facility, and Alexza’s right as licensor and manufacturer of Staccato® alprazolam. This strategic move strengthens Lee’s Pharm’s aerosolized inhalation drug delivery capabilities, expands the Company’s inhalation product pipeline, and aligns with the Company’s global expansion strategy.

The transaction remains subject to certain closing conditions and is expected to close by the end of 2025.

Proprietary And Well-Validated Staccato® One Breath Technology®

The acquisition of the Staccato® OBT® platform represents a major step forward for the Company, granting full ownership of this technology platform which is a well-validated and proven platform supported by approved product, Adasuve®, and several Staccato® based late-stage development programs. This strategic move strengthens the Company’s drug delivery capabilities and positions it to drive future innovation in inhalation therapeutics.

Synergistic and Complementary to Lee’s Pharm’s Existing Products Pipeline

The transaction also delivers significant synergies with the Company’s existing pipeline. The Company has been advancing its clinical development of Staccato® based medicine for cancer-related breakthrough pain and started commercializing Adasuve® for acute agitation in adult schizophrenia or bipolar I disorder across Greater China. Upon completion of the acquisition, all licensing payment obligations payable thereafter by Lee’s Pharm to Alexza for the development and commercialization of Staccato® based medicine and Adasuve®, will be eliminated, delivering immediate cost savings and enhancing overall deal economics.

In addition, two promising CNS pipeline assets targeting Parkinson’s disease and Cyclic Vomiting Syndrome (CVS), both at Phase 2 clinical stage, will be integrated into the Company’s portfolio, unlocking new commercial opportunities.

Acquisition of Rights as Licensor and Manufacturer of Staccato® alprazolam Under a Global Partnership With UCB

Complementing these benefits, the Company acquires Alexza’s rights and obligations under the existing worldwide licensing and manufacturing supply agreement with UCB, a biopharmaceutical with strong presence in epilepsy treatment. Under this agreement, UCB holds and will keep global development and commercialization rights for Staccato® alprazolam, which is currently in Phase 3 clinical trial (CinicalTrial.gov ID: NCT05077904), reinforcing the clinical maturity and commercial potential of the Staccato® OBT® platform. UCB acquired Engaged Therapeutics, Inc. for Staccato® alprazolam in June 2020 and entered into an updated license and related commercial supply agreement with Alexza.^[1]

Subject to achieving specified development, regulatory, and sales milestones, Lee’s Pharm together with NPI may receive milestone payments totalling up to US$60.5 million, along with tiered royalties on global net sales of Staccato® alprazolam, in addition to manufacturing revenue from worldwide supply of Staccato® alprazolam.

Note: [1] Source of reference: https://www.ucb.com/newsroom/press-releases

“Acquiring the Staccato® OBT® platform is a transformative step for Lee’s Pharm, reinforcing our commitment to innovation in inhalation therapeutics targeting CNS and neurodegenerative disorders, and expanding our global footprint.” said Dr. Benjamin Li, Founder and Director of Lee’s Pharmaceutical Holdings Limited. “This transaction not only strengthens our pipeline and inhalation R&D capabilities but also creates new revenue streams through the strategic partnerships with UCB.”

” We are delighted to partner with UCB as it commits and advances solutions to address critical unmet needs in epileptic seizure therapy. This transaction not only delivers near-term financial benefits but also positions us for sustained growth in high-value therapeutic areas, marking a significant milestone in the Company’s global expansion strategy.” said Ms. Wanee Lee, Managing Director of Lee’s Pharmaceutical Holdings Limited.

“Under the new leadership, our team is energized to continue collaborating closely with UCB and to ensure the reliable manufacture of meaningful therapy for patients with significant unmet needs. We are equally excited about the opportunity to bring additional Staccato® based medicines to patients around the world, strengthening our shared commitment to improving lives through innovative science.” said Dr. Wolfgang Schmidt, SVP Manufacturing and Operations at NPI.

About Lee’s Pharmaceutical Holdings Limited

The Company is a research-driven and market-oriented biopharmaceutical company with more than over 30 years of operation’ experience in the pharmaceutical industry in China. The Company is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives. The Company has established extensive partnerships with around 30 international companies and currently markets over 25 proprietary, generic and licensed-in pharmaceutical products in Mainland China, Hong Kong, Macau and Taiwan. The Company focuses on several key disease therapeutic areas such as cardiovascular health, woman’s health, paediatrics, rare diseases, oncology, dermatology and obstetrics.

More information available at www.leespharm.com.

About Staccato® One Breath Technology®

The Staccato® One Breath Technology® is a unique and highly differentiated drug delivery technology that delivers excipient free drug as fast as intra-venous injection, but non-invasively, resulting in rapid onset of therapeutic effect. It is best positioned for treatment of acute conditions that require quick relief. The ability of the technology with the combination of different molecules to give response to unmet medical needs in an innovative manner has been well proven in large number of clinical studies with different compounds and across number of indications.

The proprietary technology is well protected by large numbers of patents across different therapeutic areas.

More information available at https://staccatoobt.com.

BEVERLY, Mass., Dec. 10, 2025 /PRNewswire/ — Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today its participation in SEMICON Japan 2025, taking place December 17–19 at Tokyo Big Sight in Tokyo, Japan. Axcelis will exhibit in Hall 2, Booth #2655. 

Visitors will experience Axcelis’ next-generation ion implant technologies designed to boost device performance, enhance productivity, and reduce cost of ownership. Featured systems include:

• Purion Power Series+™ – Optimized for next-generation power devices, including emerging superjunction architectures. The new platform spans the full ion implant market with new extensions including Purion H200+ SiC for high current medium energy, Purion M+ SiC for medium current, and Purion XE+ SiC and Purion EXE+ SiC for high energy applications.
• Purion H™ Series – Delivers unmatched purity and precision with industry-leading productivity across the high current operating space. Features innovative scanned spot beam technology with precise implant angle and dose control to enhance device performance and yield.
• Purion XE™ Series – The industry leading high energy implant platform with the widest energy range, including the Purion XEmax model featuring our patented Boost Technology™ for the most advanced image sensor applications up to 15MeV.
• GSD Ovation™ ES – Provides best-in-class high current hydrogen and helium implant capability for engineered substrates, including wafer splitting. The new system is an evolution of the GSD Ovation Series platform, the industry benchmark for batch implanter productivity.

Special events on Thursday, Dec. 18th:

• Innovative Ion Implant Solutions for Next Generation Power Devices
  TechSPOT, Hall 5 | 15:30–15:50
  Introducing the Purion Power Series+, the next generation of ion implant solutions designed to meet evolving performance & production demands for power devices, including superjunction architectures. New solutions enable lower CoO, increase process flexibility and tighten process control.
• Axcelis Happy Hour Celebration
  Hall 2, Booth #2655 | 16:00–17:00
  Join us for beverages and appetizers and meet the Axcelis team!

President and CEO of Axcelis Technologies Dr Russell Low, said, “We’re excited to showcase our most advanced ion implant technology to Japan’s semiconductor manufacturers. Japan customers value Axcelis’ broad implant portfolio for power, image sensor, memory, and advanced logic applications. Our growing installed base and support infrastructure in Japan reflect our commitment to delivering innovative solutions that ensure customer success. We look forward to presenting our latest advancements at SEMICON Japan.”

About Axcelis:
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

AXCELIS CONTACTS:
Japan:
Russell Newman (Country Manager, Japan) +81 80 9052 5424

Global:
Maureen Hart (Editorial/Media) +1.978.787.4266
David Ryzhik (Investor Relations) +1.978.787.2352

Logo – https://laotiantimes.com/wp-content/uploads/2025/12/axcelis_1_logo.jpg

MIAMI, Dec. 10, 2025 /PRNewswire/ — The Nobel Sustainability Trust (NST) successfully hosted its 2025 Annual Summit in Miami on 5 December 2025, at the St. Regis Bal Harbour Resort, bringing together global leaders, policymakers, scientists, innovators, and entrepreneurs to accelerate solutions for a sustainable future.

Nobel Sustainability Trust Successfully Concludes 2025 Miami Summit

The summit opened with an elegant Gala Dinner moderated by renowned journalist Gloria Ordaz, featuring a welcome address by NST leadership and representatives of the Miami Dade County Mayor Daniella Levine Cava, followed by a special keynote remark by Ambassador Andrew Jackson Young and an honored VIP dignitary.

The official summit was moderated by global entrepreneur Jeff Hoffman, Chairman of the Global Entrepreneurship Network and co-founder of Priceline/Booking.com. Opening remarks were delivered by Peter Nobel, Chairman of the Nobel Sustainability Trust and remarks from Johan Rockström.

A highlight of the morning session was the Sustainability Award Ceremony, introduced by the NST Board of Directors. Ed Russo delivered a keynote speech on behalf of the President of the United States and received an official NST recognition. Additional keynote addresses were delivered by the 2025 Outstanding Contribution to Sustainability Medal awardees, H.E. Abdullah bin Hamad bin Abdullah Al Attiya and H.E. Dr. Yasmine Fouad, reinforcing global governmental commitment to sustainability.

The Academic Awards segment featured the presentation of the 2025 Sustainability Award themes by the Technical University of Munich, followed by high-level recognition for Leadership in Implementation, Outstanding Research in Biodiversity, and Intelligent & Sustainable Urban Solutions. The 2025 awardees were Prof. Manfred Curbach, Prof. Paul Hebert, and The Global Observatory for Healthy & Sustainable Cities.

In addition, NST proudly announced its official academic partnership with the University of Cambridge and its Frontier Technology Lab, marking Cambridge as a selected strategic academic partner for NST from 2026. The announcement was delivered by Simran Chana on behalf of the University of Cambridge and its Frontier Technology Lab. This new partnership will focus on frontier technologies, AI governance, sustainability innovation, and future global solutions.

In the midday program, AECOM and NST announced their strategic partnership and presented the first Smart & Sustainable City Certificate which was awarded to Lusail City, Doha.

The summit sessions explored future-shaping themes including AI & Smart Sustainable City Solutions and Biodiversity as Global Infrastructure. A keynote address on behalf of the President of Panama was delivered by H.E. the Minister of Foreign Affairs of Panama, followed by keynote interventions from Youssef Nassef, Head of the UNFCCC Adaptation Division, and Professor Graciela Chichilnisky. The program continued with two high-impact fireside chats on Climate Finance and The Next Era of Artificial Intelligence, reinforcing NST’s mission to bridge policy, science, technology, and investment for real-world impact.

With planned future summits in Doha next year, the 2025 Miami Summit reaffirmed NST’s growing role as a global platform for sustainability leadership, innovation, and international collaboration.

Nobel Sustainability Trust Successfully Concludes 2025 Miami Summit

• Globally renowned team adds to Latham’s market-leading capabilities, bringing decades of advisory experience on cutting-edge transactions.

• Significant milestone in the growth of the firm’s top-ranked private equity and M&A practice, reinforcing the firm’s leadership in Germany, across Europe, and globally.

• Arrival of team of dealmakers strengthens client offering with unparalleled buyout and M&A reputation, deep market insight, and integrated global capabilities.

FRANKFURT, Germany, Dec. 10, 2025 /PRNewswire/ — Latham & Watkins is pleased to announce that four prominent private equity and M&A partners–Markus Paul, Wessel Heukamp, Verena Nosch, and Carsten Haak–will join the firm in Germany. The partners join from Freshfields, bringing decades of advisory experience on cutting-edge transactions.

Widely recognized among Europe’s most experienced private equity lawyers, they bring extensive expertise advising a broad range of private equity and other financial sponsors, as well as corporates, including in the financial institutions sector, on a variety of transactions, with a particular focus on leveraged buyouts and complex domestic and cross-border M&A.

Rich Trobman, Chair and Managing Partner of Latham & Watkins, said: “Markus, Wessel, Verena, and Carsten are highly accomplished lawyers with outstanding reputations in the market. They bring deep relationships, top-notch skills and an exceptional track record in sophisticated transactions, further enhancing our ability to deliver the highest level of service to clients. Their arrival represents an important milestone in the continued growth of our private equity and M&A practices in Germany and Europe and further enhances our position as one of the elite M&A law firms globally.”

Strengthening Leadership in Germany and Europe

The addition of the team builds on Latham’s strong momentum in the private equity and M&A market. In the first three quarters of 2025, the firm achieved #1 global rankings for M&A by both deal value and deal count, as well as #1 for global private equity M&A by deal count (Bloomberg). In Europe, Latham also ranked #1 for M&A, private equity M&A, and mid-market private equity M&A by deal count. (Bloomberg)

Oliver Felsenstein, private equity partner in Germany, commented: “We have built one of the preeminent private equity and M&A practices in Germany, across Europe, and globally. The firm is already operating at the very top of the German market, and the addition of these exceptional lawyers raises the bar even higher. Their stellar market reputation and extensive industry networks are a perfect fit for our practice and further enhance our ability to deliver on our clients’ most consequential matters. As we approach our 25th anniversary in Germany in 2026, their arrival marks another major step in the continued growth and success of our practice in Europe and globally.” 

Global Platform, Local Expertise

Paul and Haak will join the Frankfurt office, while Heukamp and Nosch will join in Munich, strengthening Latham’s presence in Germany’s key financial and private equity centers. Working seamlessly with colleagues across the firm’s European and global platform, they will provide clients with integrated, cross-border advice across all major markets. Their arrival further strengthens Latham & Watkins’ ability to connect European clients to opportunities and expertise across the continent and beyond.

“We are thrilled to welcome Markus, Wessel, Verena, and Carsten to the firm,” added Burc Hesse, Managing Partner of Latham’s German Offices. “Their arrival is a testament to the exceptional growth we have achieved in recent years and our preeminent position in the market. The team not only strengthens our practice in Germany but also reinforces our commitment to delivering outstanding results for our clients, both in Europe and worldwide.”

Charles Ruck, Global Chair of Latham’s Corporate Department, added: “Private equity has long been a core pillar of our global strategy and the arrival of this fantastic team of dealmakers further strengthens our practice in every major market globally. As the only premier top-ranked firm globally across capital markets, private equity, M&A, banking, private credit, high yield, restructuring, and more, we have a unique offering for our client base and are well-positioned to meet their evolving needs, leveraging the breadth of our practice to move quickly and deliver excellence at scale.”

About Latham & Watkins (lw.com)

Latham & Watkins is a leading global law firm that brings together exceptional legal talent in financial centers around the world to advise on complex transactions, litigation, and regulatory matters. The firm’s deep market and product knowledge, industry experience, vast scale, and commitment to innovation and excellence help clients navigate their most critical challenges and achieve their goals.

Notes to Editors

Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership conducting the practice in Japan. Latham & Watkins operates in Israel through a limited liability company, in South Korea as a Foreign Legal Consultant Office, and in Saudi Arabia through a limited liability company.

ABU DHABI, UAE, Dec. 10, 2025 /PRNewswire/ — Abu Dhabi Finance Week (ADFW), the flagship event hosted by ADGM, continued for a second day with Asset Abu Dhabi, bringing together some of the world’s biggest capital allocators and asset managers to explore emerging investment opportunities and shape the future of asset allocation in an evolving financial landscape.

Opening the event, Emmanuel Givanakis, CEO of ADGM’s Financial Services Regulatory Authority, highlighted how Abu Dhabi continues to redefine the global asset management sector by combining robust regulation, strategic innovation, and its unique position as a nexus for global capital. His remarks set the tone for the day’s discussions around how financial centres can lead the transition towards sustainable and opportunity-driven growth.

Givanakis said: “Asset Abu Dhabi reflects the growing convergence of global capital and innovation, convening the world’s most sophisticated asset managers at a time of profound change in finance. It stands as a symbol of Abu Dhabi’s emergence as a trusted hub in the reengineering of global capital networks and the future of asset management.”

Through various sessions, the event explored the future of asset management, hedge funds, and private markets, as well as the evolving dynamics of liquidity, leverage, and institutional allocation, and the growing interplay between innovation, technology, and sustainability in driving economic transformation.

Some of the world’s foremost investment minds discussed the forces shaping tomorrow’s financial landscape. Todd Boehly, Co-Founder, Chairman and CEO of Eldridge Industries; Robert Smith, Founder, Chairman and CEO of Vista Equity Partners; and Sir Christopher Hohn, Founder and Managing Director of TCI Fund Management Limited and DAMAC founder Hussain Sajwani discussed how shifting macroeconomic cycles, emerging technologies, and geopolitical realignments will define the next phase of opportunity and risk.

With a focus on the Evolving Art of Hedge Funds, Aron Landy, CEO of Brevan Howard; Shiv Srinivasan, CIO of Hedge Funds at the Abu Dhabi Investment Council; and Robyn Grew, CEO of Man Group, examined how data, AI, and precision analytics are transforming risk management and redefining performance in a world where volatility represents opportunities.

Meanwhile, a session covering The Physics of the Great Wealth Transfer brought together Stefan Bollinger, CEO of Bank Julius Baer & Co. Ltd., and Chi Man Kwan, Group CEO and Co-Founder of Raffles Family Office, discussing how an estimated $84 trillion in intergenerational wealth will reshape economies and values worldwide.

Inaugural FCCI Report

In a separate session, Bruno Lanvin, President of the Descartes Institute for the Future and Robert Salomon, Dean of Stern at NYU Abu Dhabi, unveiled the inaugural NYU Global Financial Centre Competitiveness Index (FCCI), which evaluates international financial centres worldwide.

The index ranks New York, London, and Singapore as the top three, and highlights the GCC’s growing influence, placing Abu Dhabi No. 1 in MENA and 12^th globally, ahead of Dubai, Riyadh and Doha. Lanvin highlighted that Abu Dhabi’s position is the result of sustained institutional strength, regulatory innovation and deliberate economic strategy. The Index ranked Abu Dhabi 1st globally for Regulatory Innovation, 5th for Institutional Environment and 3rd for Business Support Incentives, noting that the emirate is demonstrating exceptional progress and an increasing role in global finance.

International Family Office Congress

Bringing together global family office leaders, this event discussed wealth preservation and the future of private capital while also exploring the shifting dynamics of global investment, the great wealth transfer, impact investing, and Abu Dhabi’s emergence as a leading hub for family offices and generational wealth creation.

The event featured Ray Dalio, Founder of Bridgewater Associates; Bhanu Baweja, Chief Strategist at UBS Investment Bank; Daniel Pinto, Co-Founder and CEO of Stanhope Capital Group; Arjun Raghavan, CEO of Partners Capital; Henry Lawson-Johnston, Managing Partner at Guggenheim Brothers Media; Benjamin Cavalli, Head of Strategic Clients at UBS Global Wealth Management; Adrian Cheng, CEO of New World Development and Founder of K11 Group; and Jim Mellon, Executive Chairman of Agronomics.

Newcomers and Major Collaborations

The second day of ADFW also saw announcements from a number of firms opening offices in ADGM. Circle Internet Group, Inc., one of the world’s leading internet financial platform companies listed on the New York Stock Exchange, strengthened its strategic presence in the region by securing a Financial Services Permission (FSP) license from the Financial Services Regulatory Authority (FSRA) of ADGM to operate as a Money Services Provider. BBVA has received an In-Principle Approval (IPA) from the FSRA, which will help them expand their range of corporate and investment banking service activities and strengthen their position as a strategic partner for corporate and institutional clients in the region.

ADFW continues for two more days with key events taking place under the umbrella of Fintech Abu Dhabi and Abu Dhabi Sustainable Finance Forum (ADSFF).